A Key Role for Lysine Residues in Amyloid β-Protein Folding, Assembly, and Toxicity
- 27 March 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 3 (6), 473-481
- https://doi.org/10.1021/cn3000247
Abstract
A combination of hydrophobic and electrostatic interactions is important in initiating the aberrant self-assembly process that leads to formation of toxic oligomers and aggregates by multiple disease-related proteins, including amyloid β-protein (Aβ), whose self-assembly is believed to initiate brain pathogenesis in Alzheimer’s disease. Lys residues play key roles in this process and participate in both types of interaction. They also are the target of our recently reported molecular tweezer inhibitors. To obtain further insight into the role of the two Lys residues in Aβ assembly and toxicity, here we substituted each by Ala in both Aβ40 and Aβ42 and studied the impact of the substitution on Aβ oligomerization, aggregation, and toxicity. Our data show that each substitution has a major impact on Aβ assembly and toxicity, with significant differences depending on peptide length (40 versus 42 amino acids) and the position of the substitution. In particular, Lys16→Ala substitution dramatically reduces Aβ toxicity. The data support the use of compounds targeting Lys residues specifically as inhibitors of Aβ toxicity and suggest that exploring the role of Lys residues in other disease-related amyloidogenic proteins may help understanding the mechanisms of aggregation and toxicity of these proteins.Keywords
This publication has 58 references indexed in Scilit:
- Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01ACS Chemical Neuroscience, 2012
- Structurally distinct toxicity inhibitors bind at common loci on β‐amyloid fibrilProtein Science, 2010
- Biophysical Characterization of Aβ42 C-Terminal Fragments: Inhibitors of Aβ42 NeurotoxicityBiochemistry, 2010
- Evidence for Novel β-Sheet Structures in Iowa Mutant β-Amyloid FibrilsBiochemistry, 2009
- Amyloid β-Protein Monomer Folding: Free-Energy Surfaces Reveal Alloform-Specific DifferencesJournal of Molecular Biology, 2008
- Structures and Free-Energy Landscapes of the Wild Type and Mutants of the Aβ21–30 Peptide Are Determined by an Interplay between Intrapeptide Electrostatic and Hydrophobic InteractionsJournal of Molecular Biology, 2008
- Effects of Familial Alzheimer’s Disease Mutations on the Folding Nucleation of the Amyloid β-ProteinJournal of Molecular Biology, 2008
- Structure and Dynamics of the Aβ21–30 Peptide from the Interplay of NMR Experiments and Molecular SimulationsJournal of the American Chemical Society, 2008
- Structural Study of Metastable Amyloidogenic Protein Oligomers by Photo‐Induced Cross‐Linking of Unmodified ProteinsMethods in enzymology, 2006
- Experimental Constraints on Quaternary Structure in Alzheimer's β-Amyloid FibrilsBiochemistry, 2005